Basic Information
Basic information for SNHG11-229-10aa-3
Peptide Name SNHG11-229-10aa-3
Genome Position chr20:38447955-38447984[+]
Species Human
Peptide Sequence MGADEIFVLH
Peptide Length 10
Unique No (SNHG11-202-10aa-1,SNHG11-203-10aa-1,SNHG11-206-10aa-1,SNHG11-209-10aa-1,SNHG11-210-10aa-2,SNHG11-219-10aa-1,SNHG11-221-10aa-2,SNHG11-222-10aa-1,SNHG11-223-10aa-1,SNHG11-224-10aa-1,SNHG11-225-10aa-2,SNHG11-226-10aa-2,SNHG11-227-10aa-2,SNHG11-230-10aa-1,SNHG11-231-10aa-1,SNHG11-232-10aa-1,SNHG11-235-10aa-1,SNHG11-238-10aa-2)
Grand Average of Hydropathicity 0.84
Relative Molecular Mass 1293.44
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000174365;SNHG11
Transcript ID/Name ENST00000663763;SNHG11-229
Transcript Length 4108
Coding Ability 0.4056
DNA Sequence Corresponding to Peptide ATGGGGGCAGATGAGATCTTTGTACTGCAT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :